OPRL1 encodes the nociceptin receptor (NOP), a G protein-coupled receptor that binds the endogenous neuropeptide nociceptin to modulate pain perception and locomotor activity [UniProt]. The receptor signals through inhibition of adenylate cyclase and calcium channels, with alternative arrestin-mediated pathways activating MAP kinases [UniProt]. OPRL1 dysfunction associates with multiple neuropsychiatric and neurodegenerative conditions. Genetic polymorphisms in OPRL1 are linked to alcohol dependence, with SNP rs6010718 showing significant association in Scandinavian populations 1. OPRL1 methylation emerges as a critical epigenetic regulator: low intron 1 methylation mediates psychosocial stress-induced binge drinking through altered ventral striatum reward processing 2, while elevated promoter methylation is associated with Alzheimer's disease and serves as a potential diagnostic biomarker 3. Environmental stressors during early life increase hippocampal Oprl1 expression through histone modifications, potentially contributing to cognitive impairment in male offspring 4. Functionally, OPRL1 demonstrates anti-inflammatory properties, with NFκB signaling regulating NOP transcription during inflammatory responses 5. In PTSD, OPRL1 variants associate with amygdala-dependent fear processing and trauma susceptibility; NOP receptor agonists impair fear memory consolidation 6. These findings establish OPRL1 as a convergent hub linking stress, reward processing, inflammation, and fear circuitry.